Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. - Wikidata - awgldk - TriplyDB

Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results.

Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results.

http://www.wikidata.org/entity/Q39024055

about

False Negative NIPT Results: Risk Figures for Chromosomes 13, 18 and 21 Based on Chorionic Villi Results in 5967 Cases and Literature Review Recent advances in prenatal genetic screening and testing Copy-number variation and false positive prenatal aneuploidy screening results.Clinical Utility of Non-Invasive Prenatal Screening from Maternal Blood.Six consecutive false positive cases from cell-free fetal DNA testing in a single referring centre The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform.Positive predictive value of non-invasive prenatal screening for fetal chromosome disorders using cell-free DNA in maternal serum: independent clinical experience of a tertiary referral center Chromosomal Mosaicism in Human Feto-Placental Development: Implications for Prenatal Diagnosis.Unexplained False Negative Results in Noninvasive Prenatal Testing: Two Cases Involving Trisomies 13 and 18.Cell-free fetal DNA in the maternal circulation originates from the cytotrophoblast: proof from an unique case.Comparison of two high-throughput semiconductor chip sequencing platforms in noninvasive prenatal testing for Down syndrome in early pregnancy An adaptive detection method for fetal chromosomal aneuploidy using cell-free DNA from 447 Korean women.Statistical Approach to Decreasing the Error Rate of Noninvasive Prenatal Aneuploid Detection caused by Maternal Copy Number Variation To NIPT or Not to NIPT.Noninvasive prenatal testing in the general obstetric population: clinical performance and counseling considerations in over 85 000 cases.Pre- and post-test genetic counseling for chromosomal and Mendelian disorders.Enlarged NT (≥3.5 mm) in the first trimester - not all chromosome aberrations can be detected by NIPT.Single Nucleotide Polymorphism-Based Analysis of Cell-Free Fetal DNA in 3000 Cases from Germany and Austria Implementation of non-invasive prenatal testing by semiconductor sequencing in a genetic laboratory Cell-free DNA testing of an extended range of chromosomal anomalies: clinical experience with 6,388 consecutive cases.Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening.Cytogenetic confirmation of a positive NIPT result: evidence-based choice between chorionic villus sampling and amniocentesis depending on chromosome aberration.Survey of US obstetrician opinions regarding NIPT use in general practice: implementation and barriers.Expanding non-invasive prenatal testing beyond chromosomes 21, 18, 13, X and Y.Analysis of false-positive results of fetal RHD typing in a national screening program reveals vanishing twins as potential cause for discrepancy.Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods.Discordant non-invasive prenatal testing (NIPT) - a systematic review.Validation of a method for noninvasive prenatal testing for fetal aneuploidies risk and considerations for its introduction in the Public Health System.Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.Frequency of fetal karyotype abnormalities in women undergoing invasive testing in the absence of ultrasound and other high-risk indications.Chorionic villus sampling fails to confirm mosaic trisomy 21 fetus after positive cell-free DNA.Noninvasive prenatal diagnosis of fetal aneuploidy by circulating fetal nucleated red blood cells and extravillous trophoblasts using silicon-based nanostructured microfluidics.Prenatal reflex DNA screening for trisomies 21, 18, and 13.Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure.Confined placental mosaicism for 22q11.2 deletion as the etiology for discordant positive NIPT results.Implications of fetoplacental mosaicism on cell-free DNA testing for sex chromosome aneuploidies.Amniocentesis is still the best option for advanced genomic testing in case of fetal malformations.Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: results of the TRIDENT study.Detection of fetal duplication 16p11.2q12.1 by next-generation sequencing of maternal plasma and invasive diagnosis.

P2860

Q26771694-F2AB06DA-4A9F-4ED6-A1A2-BDF840AA8BAC Q28071888-53284763-A90D-4F72-8E26-E57A95F38490 Q30643919-9E181BC8-BAA6-4F70-8AFC-164413463D7B Q33572406-4AD4D887-D879-44C5-8DC8-795208917C33 Q34295095-97CA20A4-E670-425B-8A60-64B04DCEFD2E Q34374066-D2592103-F1FF-455E-8206-8CE697FFC0CC Q35649161-89426BF9-0AFB-455F-BE3D-E8A9AF559B62 Q35667141-684C561C-C860-42D9-B6C1-33542D0C337C Q35763064-FFB0B106-4040-40BE-A01C-0EB5C5586362 Q35841830-8DA03C64-7E5F-47FD-AF7D-744A1D847DF0 Q36003623-5477B999-357A-46F0-A6B0-11319337773F Q36157384-50EBCEB6-7863-448E-B7EC-E23C8D2D5D2C Q36245906-D1134C02-45ED-48A3-A28B-2981CF4C1232 Q36325760-E448F3FA-0FCF-4FF3-8A28-6F8633EEBEA5 Q36762710-F538DF8B-B81A-4071-BA15-F1CD49954FC6 Q36784201-6C143B26-51D1-4BC7-8A7B-F552B65DBC37 Q37240193-F902CFCF-E218-4E33-9811-58928F2B4135 Q37255859-70B37FD2-2D9D-4C17-AEC2-9624BA27E915 Q37412801-3CBAED29-1E04-46D0-B8E9-64166FB8BF54 Q37637591-1A60FF61-63B2-4530-95C3-C9D00AB1856C Q37716310-7F03CC79-D58F-47E8-B62F-6BF5E4BA4198 Q38728695-423F73E7-B19B-4888-A2AF-3664F49FA34E Q38824972-67F74849-3A91-4007-B237-F11CBFFDE849 Q38860845-F4B3D571-4CAC-4B41-925D-98B4252C81BB Q38889509-36BE4787-2AA2-4481-B84E-7041213C5DC2 Q38895114-3C8EEF93-A73A-47FF-9C76-0BCE4AA3FC93 Q39223783-2F722868-2FB7-410D-BF63-368E9F9F7793 Q39735567-F22EAA8A-A3DD-4A0D-A0EF-B381831132A7 Q40053463-32D039E0-3997-4578-8223-699CAAD8B739 Q40524568-EAF0DFB9-2900-4EC7-A727-4CD79196EA91 Q46149420-54A8BB76-8A17-437B-9F86-56BC220B0D6F Q46181819-640F3FEA-D46F-46C6-A5A6-423577ED640A Q47421797-5DA341B4-BC78-4608-AACE-EDD96D79F243 Q47618331-F0E97D64-8F68-4946-9DBF-A43EF798FD3E Q48154335-92F9456D-C21C-4E0F-97CA-0CDDC12BAA2E Q48235938-57C0AA4C-B87C-4E27-9289-007830E6CECB Q48249497-94EFB87F-3917-40E6-8066-E5D0BE5B575A Q48280857-89127B8D-61C6-4840-AF68-CA68B8E2FC36 Q50093623-FC16060B-3262-4920-832E-D3907B12F7F3 Q50204931-F0567D13-617A-419B-990C-2570C4123FEE

P2860

Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results.

http://www.wikidata.org/entity/Q39024055

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Fetoplacental mosaicism: poten ...... ve prenatal screening results.

@en

Fetoplacental mosaicism: poten ...... ve prenatal screening results.

@nl

type

label

Fetoplacental mosaicism: poten ...... ve prenatal screening results.

@en

Fetoplacental mosaicism: poten ...... ve prenatal screening results.

@nl

prefLabel

Fetoplacental mosaicism: poten ...... ve prenatal screening results.

@en

Fetoplacental mosaicism: poten ...... ve prenatal screening results.

@nl

P1433

Q39024055-4413C0AD-F900-434F-8419-33334527A482

P1476

Q39024055-D726CFD3-83AB-4C3D-B433-A28085532B2E

P2093

Q39024055-09099DF9-5468-48B9-826A-1F0367ED8DF7

Q39024055-22F9BA49-A15E-4927-AAA7-FED8FD485557

Q39024055-40BC29F8-069B-4548-9D29-3ABD4FF3BB34

Q39024055-5BE1FF60-8FA2-46DA-8F55-7AD497597294

Q39024055-65F2014E-72FA-4E98-BD54-D86A92ADCB54

Q39024055-9B544120-5677-40BD-A093-D6F312BD61A7

Q39024055-B37B258A-0E43-4D46-95C8-FE5DB4443797

Q39024055-B5E1014F-AC35-43DA-92C4-D88A30052A1E

Q39024055-CF7A57AC-9C45-47D4-A9C5-02107C31CF9E

Q39024055-DD7C395D-ACD9-47F6-B6B1-6329A370D9CB

P2860

Q39024055-1BFB0F2F-9E2C-4B56-83FF-DBE269A1364E

Q39024055-2037BC25-CE18-494A-90F0-4971E494E7B6

Q39024055-229C9241-5F65-4106-A2E8-FBD0F6F92A52

Q39024055-34097405-8B96-4150-86BC-E6E7BBC86663

Q39024055-4ADA4990-3A49-41C8-A156-D2B215CA49C2

Q39024055-4DB9D1BB-92D3-4255-8600-DB728C8EF411

Q39024055-805B1783-6C86-49E4-8DC7-653B678A11A4

Q39024055-86CCEE4C-B611-400F-8ADF-91FAD51EB0E6

Q39024055-8EF1D486-1AEE-44F3-BA87-A95415A2240D

Q39024055-98CFD302-FF8D-4146-9D27-E6D0D23575EC

P2888

Q39024055-5FCD92CD-E176-405D-BA5D-8698A790F3D7

P304

Q39024055-450D18AE-C728-4A70-84DB-04F5E2ABE772

P31

Q39024055-3A65880B-F075-4424-A90E-6AA85A263DD5

P356

Q39024055-4FD7D6E2-4340-481C-9D6F-40529FE9799F

P407

Q39024055-AC28BB10-31E5-4031-951E-F7678EF2B58F

P433

Q39024055-10E57611-A0FD-452A-9CA9-935E13015B4E

P478

Q39024055-7E6674F9-B914-46CD-A1D0-F27DC9042380

P50

Q39024055-4AE37414-8EB1-4C68-968D-15F589D9281D

Q39024055-F23BC51A-6FE0-4E00-9B83-7EFBE7AA45C5

P577

Q39024055-B1018695-AC3F-4F7B-A7DD-4941647D6135

P5875

Q39024055-4AF28CDC-F143-4EB1-BBC4-9956C613D99A

P698

Q39024055-6E6499CA-468F-4405-9305-AAE1BBBD94E6

P356

P1433

Genetics in Medicine

P1476

Fetoplacental mosaicism: poten ...... ive prenatal screening results

@en

P2093

Anna M Ruggeri

http://www.w3.org/2001/XMLSchema#string

Beatrice Grimi

http://www.w3.org/2001/XMLSchema#string

Cristina Agrati

http://www.w3.org/2001/XMLSchema#string

Elisa Gaetani

http://www.w3.org/2001/XMLSchema#string

Federico Maggi

http://www.w3.org/2001/XMLSchema#string

Francesca Dulcetti

http://www.w3.org/2001/XMLSchema#string

Francesca Malvestiti

http://www.w3.org/2001/XMLSchema#string

Francesca R Grati

http://www.w3.org/2001/XMLSchema#string

Giuseppe Simoni

http://www.w3.org/2001/XMLSchema#string

Ronald Wapner

http://www.w3.org/2001/XMLSchema#string

P2860

Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testing

Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study.

Cell-free fetal nucleic acids in amniotic fluid

Trophoblastic oxidative stress and the release of cell-free feto-placental DNA.

Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples.

Non-invasive prenatal testing for aneuploidy: current status and future prospects.

Confirmation of mosaicism and uniparental disomy in amniocytes, after detection of mosaic chromosome abnormalities in chorionic villi.

Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?

Cell-free fetal DNA testing: who is driving implementation?

P2888

P304

620-624

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GIM.2014.3

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Jose Carlos Ferreira

P577

2014-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260195772

http://www.w3.org/2001/XMLSchema#string

P698

24525917

http://www.w3.org/2001/XMLSchema#string